Laura Buburuzan
Papers
1
Total Citations
64
H-Index
1
About
Dr. Laura Buburuzan is a pioneering researcher at the intersection of oncology and computational medicine, whose work is reshaping early cancer detection. Her primary research focuses on leveraging liquid biopsy and artificial intelligence to identify molecular signatures of colorectal malignancies, a leading cause of cancer-related mortality worldwide. Her most influential work, the 2022 paper "Liquid Biopsy and Artificial Intelligence as Tools to Detect Signatures of Colorectal Malignancies," has garnered 64 citations, underscoring its significance in the field. In this study, she demonstrates how combining non-invasive blood-based biomarkers with AI-driven analysis can revolutionize patient stratification, enabling earlier diagnosis when prognosis is most favorable. Dr. Buburuzan’s contributions address a critical gap: despite advances in treatment, colorectal cancer outcomes remain tightly linked to disease stage at detection. By developing tools that catch malignancies earlier, her research promises to improve survival rates and reduce the burden on healthcare systems. Her work stands as a modern, data-driven approach to one of public health’s most pressing challenges, positioning her as a key voice in precision oncology.
Research Focus
Key Achievements
Top Papers
- 1